Skip to main content
$536.94 -$12.13 (-2.2%)

04:00 PM EDT on 09/28/21

DexCom, Inc. (NASDAQ:DXCM)

CAPS Rating: 4 out of 5

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.

Current Price $536.94 Mkt Cap $53.1B
Open $540.94 P/E Ratio 97.40
Prev. Close $536.94 Div. (Yield) $0.00 (0.0%)
Daily Range $522.92 - $542.51 Volume 557,838
52-Wk Range $305.63 - $579.00 Avg. Daily Vol. 556,727

Caps

How do you think NASDAQ:DXCM will perform against the market?

Add Stock to CAPS Watchlist

All Players

306 Outperform
98 Underperform
 

All-Star Players

98 Outperform
17 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DXCM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

FighterFlash (41.97)
Submitted August 11, 2020

My dad has type 1 Dexcom has added years to his life. There are issues it still needs to be calibrated and does lag but this is going to exponentially improve. Also we had a global pandemic and want to know what people are bullish on carb’s and… More

TMFjimhalley (30.24)
Submitted November 13, 2020

The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.

Recent Community Commentary

Read the most recent pitches from players about DXCM.

Recs

0
Member Avatar Car12703 (53.04) Submitted: 5/7/2021 11:39:22 AM : Outperform Start Price: $365.45 NASDAQ:DXCM Score: +44.26

From Fidelity May 2021:
Revenue Growth (Last 5 Years) = 36.8%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 24.7%
Price/Sales (TTM) = 16.9

Recs

0
Member Avatar davlimyg (< 20) Submitted: 2/13/2021 7:03:44 AM : Outperform Start Price: $411.00 NASDAQ:DXCM Score: +20.55

Solves a big problem, but the competition is no slouch either. Will continue to invest in growing the overall market. Still a long runway

Recs

0
Member Avatar Oranicus (85.33) Submitted: 2/8/2021 4:27:06 PM : Outperform Start Price: $409.23 NASDAQ:DXCM Score: -7.10

the besof breed in Diabetes

Leaderboard

Find the members with the highest scoring picks in DXCM.

Score Leader

ardys13

ardys13 (< 20) Score: +14,006.37

The Score Leader is the player with the highest score across all their picks in DXCM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ardys13 < 20 2/9/2009 Outperform 1Y $3.70 +14,411.89% +405.52% +14,006.37 1 Comment
bigrick22 < 20 3/24/2008 Outperform NS $4.00 +13,323.50% +237.39% +13,086.11 0 Comment
CleverKat 67.30 3/24/2008 Outperform NS $4.27 +12,474.71% +233.71% +12,240.99 0 Comment
cpalerm 87.91 3/23/2009 3/13/2014 Outperform 5Y $4.32 +12,329.17% +456.58% +11,872.59 1 Comment
MEGIN7790 < 20 4/4/2008 Outperform NS $4.45 +11,966.07% +227.31% +11,738.76 0 Comment
LazyTimeMoney 69.96 4/7/2008 Outperform NS $5.04 +10,553.57% +226.76% +10,326.82 0 Comment
jabrink 76.83 4/7/2008 Outperform 3W $5.07 +10,490.53% +226.49% +10,264.04 0 Comment
GriffinRex 89.68 4/8/2008 Outperform 3M $5.17 +10,285.69% +230.15% +10,055.54 0 Comment
cash4metoo 63.57 5/28/2009 Outperform 1Y $5.34 +9,955.06% +384.47% +9,570.59 0 Comment
YahooSIRIous 92.40 7/13/2009 Outperform 5Y $5.35 +9,936.26% +393.49% +9,542.77 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DXCM.